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Key points
• Cyclic AMP (cAMP), produced from ATP and the enzyme adenylyl cyclase (AC), plays an
important role in the regulation of pancreatic exocrine cells.
• We identified five AC isoforms in pancreatic exocrine cells. AC3, AC4, AC6 and AC9 are
expressed in both pancreatic acini and duct fragments, whereas AC7 is expressed only in duct
fragments.
• In mice deficient in AC6, cAMP formation and protein kinase A activation were impaired. As a
consequence, a reduction in amylase secretion and pancreatic fluid production was observed.
• These results indicate that AC6 plays a regulatory role in pancreatic exocrine cells.
Abstract Both secretin and vasoactive intestinal polypeptide (VIP) receptors are responsible for
the activation of adenylyl cyclases (ACs), which increase intracellular cyclic AMP (cAMP) levels in
the exocrine pancreas. There are nine membrane-associated isoforms, each with its own pattern
of expression and regulation. In this study we sought to establish which AC isoforms play a
regulatory role in pancreatic exocrine cells. Using RT-PCR, AC3, AC4, AC6, AC7 and AC9 were
found to be expressed in the pancreas. AC3, AC4, AC6 and AC9were expressed in both pancreatic
acini and ducts, whereas AC7 was expressed only in pancreatic ducts. Based on known regulation
by intracellular signals, selective inhibitors and stimulators were used to suggest which isoforms
play an important role in the induction of cAMP formation. AC6 appeared to be an important
isoform because protein kinase A (PKA), PKC and calcium all inhibited VIP-induced cAMP
formation, whereas calcineurin or calmodulin did not modify the response to VIP. Mice with
genetically deleted AC6were studied and showed reduced cAMP formation and PKA activation in
both isolated pancreatic acini and duct fragments. The absence of AC6 reduced cAMP-dependent
secretagogue-stimulated amylase secretion, and abolished fluid secretion in both in vivo and
isolated duct fragments. In conclusion, several AC isoforms are expressed in pancreatic acini and
ducts. AC6 mediates a significant part of pancreatic amylase and fluid secretion in response to
secretin, VIP and forskolin through cAMP/PKA pathway activation.
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Abbreviations AC, adenylyl cyclase; 8-Br-cAMP, 8-bromoadenosine 3′,5′cyclic monophosphate sodium salt;
cAMP, cyclic AMP; CCh, carbachol; CCK-8, sulfated cholecystokinin octapeptide; CFTR, cystic fibrosis trans-
membrane conductance regulator; CPT-cAMP, 8-(4-chlorophenylthio)adenosine 3′,5′-cyclic monophosphate sodium
salt; FSK, forskolin; IBMX, 3-isobutyl-1-methylxantine; 8-pCPT-2′-O-Me-cAMP, 8-(4-chlorophenylthio)-2′-O-
methyladenosine-3′,5′-cyclic monophosphate; PMA, phorbol 12-myristate 13-acetate; PK, protein kinase; SBTI,
soybean trypsin inhibitor; VIP, vasoactive intestinal polypeptide; VPAC, vasoactive intestinal polypeptide receptor.
Introduction
The exocrine pancreas is primarily composed of acini
and ducts. Pancreatic acini release digestive enzymes
into the duodenum to break down dietary constituents,
whereas pancreatic ducts secrete a bicarbonate-rich
fluid to neutralize the acidic chyme from the stomach.
Gastrointestinal hormones and neurotransmitters act on
specific receptors to activate several intracellular signals
that regulate these physiological processes. Cyclic AMP
(cAMP) is one of the intracellular signals and secretin and
vasoactive intestinal polypeptide (VPAC) receptors are
responsible for the increase in cAMP levels (Argent et al.
2012). Stimulation of cAMP-dependent protein kinase A
(PKA) induces phosphorylation of several cellular targets,
including activation of the cystic fibrosis transmembrane
conductance regulator (CFTR) and 1,4,5-IP3 receptors
(Williams & Yule, 2012).
Adenylyl cyclases (ACs) are enzymes which produce
cAMP from ATP. To date, at least 10 different AC
isoforms have been cloned and identified: nine ACs are
hormonally regulated and associated with membranes
and one, AC10, is cytosolic. Most tissues express several
AC isoforms and, although all membrane-associated
ACs are activated by Gαs, each isoform displays complex
and distinctive regulatory properties. Based on that, ACs
associatedwithmembranes are classified into four groups:
Group I consists of calcium/calmodulin-stimulated AC1,
AC3 and AC8; Group II consists of Gβγ-stimulated
AC2, AC4 and AC7; Group III consists of
Giα/calcium/PKC/PKA-inhibited AC5 and AC6; and
Group IV consists of calcium/calcineurin-inhibited AC9,
which is forskolin-insensitive (Willoughby & Cooper,
2007; Sadana & Dessauer, 2009). Recently, AC9 activity
has also been shown to be inhibited by Gαi/o proteins
and PKC (Cumbay &Watts, 2004).
An increase in cAMP levels is involved in evoked
pancreatic amylase and bicarbonate-rich fluid secretions;
however, the expression profile of AC isoforms in each
cell type and which isoforms mediate specific function
is unknown. In fact, current understanding of the role
of AC in pancreatic exocrine cells comes primarily from
studies that use stimulators and inhibitors of intracellular
signals (Collen et al. 1982; Gardner et al. 1983; Burnham
et al. 1984; Burnham & Williams, 1984; O’Sullivan &
Jamieson, 1992;Matsushita et al. 1993; Ohnishi et al. 1994;
Stryjek-Kaminska et al. 1995; Akiyama et al. 1998).
In this study we establish (1) which
membrane-associated AC isoforms are expressed in
the intact pancreas, as well as in purified pancreatic
acini and duct fragments, and (2) which AC isoform is
necessary for the activation of the cAMP/PKA pathway
and, as a consequence, for the secretory function in both
pancreatic exocrine cells.
Methods
Ethical approval
Animals received care according to protocols approved by
the University of Michigan Committee on Use and Care
of Animals.
Materials
Collagenase (CLSPA) was purchased from Worthington
Biochemical Co. (Lakewood, NJ, USA), collagenase
P from Roche (Penzberg, Germany), bovine albumin
fraction V (BSA) from MP Biomedicals (Solon, OH,
USA), sulfated cholecystokinin octapeptide (CCK-8)
from Research Plus (Bayonne, NJ, USA), H-89, forskolin,
3-isobutyl-1-methylxantine (IBMX), 8-bromoadenosine
3′,5′cyclic monophosphate sodium salt (8-Br-cAMP),
8-(4-chlorophenylthio)adenosine 3′,5′-cyclic mono-
phosphate sodium salt (CPT-cAMP) and soybean
trypsin inhibitor (SBTI) from Sigma Chemical (St
Louis, MO, USA), 8-(4-chlorophenylthio)-2′-O-
methyladenosine-3′,5′-cyclic monophosphate (8-pCPT-
2′-O-Me-cAMP) from Biolog Life Science Institute
(Bremen, Germany), DMEM and McCoy’s 5A tissue
culture medium from Invitrogen (Carlsbad, CA, USA),
A23187, phorbol 12-myristate 13-acetate (PMA), W-7,
FK-506, BAPTA-AM and GF-109203X from Calbiochem
(La Jolla, CA, USA), and vasoactive intestinal polypeptide
(VIP) and secretin from American Peptides (Sunnyvale,
CA, USA). Other chemical reagents were obtained from
Sigma Chemical.
Antibodies
Antibodies against the following proteins were used: goat
polyclonal antibody to AC9 (sc-8576) from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); rabbit polyclonal
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antibody to α-amylase (A-8273) and mouse monoclonal
antibody toβ-tubulin Clone TUB 2.1 (T5201) fromSigma
Chemical; mouse monoclonal antibody to Epac1 (#4155)
and rabbit polyclonal antibody to PKA RI- α/β (#3927)
from Cell Signaling Technology (Beverly, MA, USA);
mouse monoclonal antibody to Rap1 (610195) from BD
Transduction Laboratories (San Diego, CA, USA); and rat
monoclonal antibody to keratin 19 (TROMA-III) from
the Developmental Studies Hybridoma Bank, University
of Iowa.
Animals
AC6-deficient mice were prepared as described (Tang
et al. 2008). Male C57BL/6J AC6−/− mice were bred
in our facilities from heterozygotes and maintained
on a 12/12 h light–dark cycle with free access to
water and food (5001 Rodent Diet; PMI Nutrition
International, St Louis, MO, USA). Littermate WT
mice were used as controls. Expression of AC6 was
analysed by RT-PCR using the following primers:
forward: 5′GCGGCCTGGGCCTCTCTACT3′ and reverse:
5′GCGGCCTGGGCCTCTCTACT3′ (336 bp) (Tang et al.
2008).When required,micewere killed in aCO2 chamber.
Histology
Small blocks of pancreas were fixed with 10% formalin,
embedded in paraffin blocks, processed for haematoxylin
and eosin staining and examined with a Nikon Eclipse
TE200 inverted microscope equipped with a digital
camera. For immunolocalization of amylase and keratin
19, tissues were fixed for 30min with 1% formaldehyde
(freshly prepared from paraformaldehyde), and cryostat
sectionswere cut at 6μmthickness as previously described
(Sans et al. 2011) and mounted on SuperFrost Plus slices
(Fischer, Houston, TX, USA) and incubated with PBS
containing 2% normal goat serum and 0.3% Triton X-100
followed by a rabbit polyclonal antibody to α-amylase
(diluted 1:5000) and a rat monoclonal anti-TROMA-III
antibody (diluted 1:15). The sections were washed with
PBS and incubatedwith 1:500 dilutions of goat anti-rabbit
secondary antibody conjugated to Alexa 488 and goat
anti-rat secondary antibody conjugated to Alexa 594.
Fluorescence images were captured with an Olympus
wide-field microscope and processed with Adobe Photo-
shop software.
Isolation of pancreatic acini
Pancreatic acini fromWT or AC6−/− mice were prepared
by enzymatic digestionwith collagenase (CLSPA) followed
by mechanical shearing as previously reported (Sabbatini
et al. 2008).
Isolation and culture of duct fragments
Ducts were isolated from mouse pancreas and cultured
overnight following methods previously described
(Ishiguro et al. 1996). Mouse pancreas obtained from
WT or AC6−/− mice was digested using 5mg collagenase
P (Roche) dissolved in 5ml DMEM containing 0.1%
BSA and 0.01% trypsin inhibitor (SBTI) and injected
into the pancreas using a 27-gauge needle. Pancreases
were incubated for 30min at 37◦C in a polypropylene
Erlenmeyer flask with shaking at 140 r.p.m. This process
was followed by vigorous hand shaking to disrupt the
pancreas until the suspension became homogeneous. The
suspension was then briefly centrifuged and the pellet
resuspended with 20ml DMEM containing 0.1% BSA,
0.01% SBTI and antibiotics and placed in a 150mm Petri
dish. Duct fragments were hand-picked using a 20μl
pipette and placed in a 35mm Petri dish containing
sterile McCoy’s 5A tissue culture medium supplemented
with 10% (v/v) fetal bovine serum, 2mM L-glutamine,
0.15 mgml−1 trypsin inhibitor, 0.1 IUml−1 insulin and
4μgml−1 dexamethasone. Pancreatic acini and islets were
isolated in the same way and placed in a 35mm Petri
dish with DMEM containing 0.1% BSA plus 0.01% SBTI.
This step was repeated several times to remove loosely
attached cells. For measurement of cAMP levels and
PKA activity, overnight incubated duct fragments were
hand-picked and placed in a 35mm Petri dish containing
DMEM without phenol red, 0.1% BSA and 0.01% SBTI.
For measurement of ductal secretion in vitro, 24–30 h
incubated duct fragments whose lumen was easy to see
were hand-picked and placed in a tissue culture dishwith a
cover glass bottom coated with poly-D-lysine containing a
bicarbonate-buffered solution (115mM sodium chloride,
5 mM potassium chloride, 1 mM calcium chloride, 1 mM
magnesium chloride, 10 mM D-glucose, 25 mM sodium
bicarbonate equilibrated with 95% O2/5% CO2 and
adjusted to pH 7.4).
Detection of the expression of AC isoforms
Expression of the nine different membrane-associated
isoforms of AC in mouse intact pancreas, pancreatic
acini, islets and duct fragments was assessed by RT-PCR.
Total RNA was isolated from brain, kidney, parotid
gland and pancreas using TRIzol reagent (Invitrogen),
as well as from pancreatic acini, duct fragments and
islets using an RNeasy R© Mini kit (Qiagen, Valencia, CA,
USA). First-strand cDNA was synthesized with a TaqMan
RT-PCR kit (Applied Biosystems, Branchburg, NJ, USA).
Intactness of RNA was assessed based on OD260/280 and
agarose gel electrophoresis. One microgram of cDNA
was used in each PCR reaction. Amplification with Taq
DNA polymerase from ExpandHigh Fidelity EnzymeMix
kit (Roche Diagnostics, IN, USA) was conducted using
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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specific primers indicated in Supplemental Table S1. The
relative expression of each isoform in pancreatic acini and
ducts compared with the intact pancreas was evaluated
by real-time quantitative PCR analysis using Absolute
Blue SYBR Green ROX mix (Thermo Fisher Scientific,
Waltham, MA, USA) and CFX96TM cycler (Bio-Rad
laboratories, Hercules, CA). These PCR primers are listed
in Table S2. To validate the amplification efficiency of each
primer, RNA dilution series from mouse pancreas were
made for each primer, and the slope of the calibration
curve was analysed. Only primers showing efficiencies
between 90 and 100% (−3.6 ≥ slope ≥ −3.3) were used.
β-Actin was used as a reference.
Measurement of cAMP levels
cAMP levels were measured as previously reported
(Sabbatini et al. 2003). Pancreatic acini or overnight
incubated duct fragments were preincubated for 30min
in DMEM without phenol red and then for 3min in
fresh DMEMwithout phenol red containing 1mM IBMX.
Acini or ducts were stimulated with either VIP (10 nM),
secretin (100 nM) or forskolin (20μM) for 12min. cAMP
was extracted in absolute ethanol and measured using a
cAMP colorimetric enzyme immunoassay kit according to
the instructions provided by the manufacturer (Cayman
Chemical, Ann Arbor, MI, USA). Results are expressed as
picomoles per milligram protein from acini lysate or pico-
moles per microgram protein from duct fragment lysate.
Measurement of PKA activity
PKA activity was measured using a non-radioactive
colorimetric solid phase enzyme-linked
immuno-absorbent assay kit (no. ADI-EKS-390A;
Enzo Life Sciences, Plymouth Meeting, PA, USA). Results
are expressed as nanograms active PKA per microgram
protein.
Measurement of amylase secretion
Amylase secretion was measured as previously reported
(Sabbatini et al. 2008). Acini from WT or AC6−/− mice
were stimulated with VIP (0.1, 1, 10, 100 nM), secretin
(100 nM), forskolin (20μM) or CCK (10 pM, 30 pM,
100 pM, 1 nM), carbachol (10μM), CPT-cAMP (100μM)
or 8-pCPT-2′-O-Me-cAMP (100μM) for 30min. Results
are expressed as a percentage of initial acinar amylase
content.
Measurement of ductal lumen expansion
Serial transmitted light images of pancreatic duct
fragments were acquired by a Nikon A1 confocal micro-
scope (20× objective lens) every 2min for the indicated
time. The Nikon TiE inverted microscope has a Tokai Hit
(Shizuoka-ken, Japan) stage-top environmental chamber
whose temperature is controlled at 37◦C by a thermo-
stat. The expansion of duct lumen was calculated in each
recorded image using the image analysis feature of Nikon
Image System (NIS) Elements version 4.0. After a 16min
basal period, duct fragments from WT or AC6−/− mice
were stimulatedwithVIP (10 nM)or 8-Br-cAMP(500μM)
at 37◦C and monitored for an additional period. The
increase in the lumen is expressed as a fold increase over
the period recording in respect to basal (time 0).
Measurement of pancreatic fluid in vivo
Isoflurane-anaesthetized WT or AC6−/− mice were pre-
pared with a cannula into the bile duct near the liver
and another one near the ampulla of Vater to collect
pure pancreatic fluid as previously reported (Sans et al.
2011). Fluid was allowed to flow for 15min after which
basal secretion was collected for 30min prior to intra-
venous stimulation with secretin (2 U kg−1 body weight)
or VIP (0.5μg kg−1 body weight). Results are expressed as
nanolitres per 30min per gram body weight.
Statistical analysis
Results are expressed as means± SEM of 3–6 separate
experiments. The statistical analysis was performed
by analysis of variance (ANOVA) following by
Student–Newman–Keuls test. A P value of 0.05 or less
was considered statistically significant.
Results
Multiple AC isoforms are expressed in pancreatic
exocrine cells
Using RT-PCR we found five different AC mRNAs in
the intact pancreas: AC3, AC4, AC6, AC7 and AC9
(Fig. 1). AC1, AC2, AC5 and AC8 mRNAs were expressed
in their respective positive control tissues, but not in
the pancreas (Fig. 1). We then studied the expression
of AC isoforms in pancreatic acini, ducts and islets.
Expression of amylase, insulin and keratin 19 in pancreatic
acini, islets and duct fragments, respectively, indicated
the purity of the pancreatic cell preparation (Fig. 2A and
B). In isolated pancreatic acini we found that AC3, AC4,
AC6 and AC9 mRNAs are expressed, whereas in isolated
pancreatic duct fragments and islets AC3, AC4, AC6, AC7
and AC9 mRNA are expressed (Fig. 2C). Using real-time
quantitative PCR we evaluated the relative amounts of
each isoform in pancreatic acini and ducts related to
the intact pancreas. First, we confirmed the purity of
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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the acini and duct preparation. Mean cycle threshold
(CT) values are presented for transcripts corresponding to
amylase, insulin, keratin 19, and AC isoforms AC3, AC4,
AC6, AC7 and AC9 (Table 1). The results show that iso-
lated pancreatic acini have statistically significantly higher
transcript levels of AC6 and lower transcript levels of
insulin compared with intact pancreas. Keratin 19 and
AC7 were not detected in pancreatic acini. Isolated duct
fragments showed statistically significantly higher trans-
cript levels of keratin 19, AC4, AC6 and AC7 and lower
transcript levels of amylase and insulin compared with the
intact pancreas. Similar transcript levels of AC3 and AC9
were observed in pancreas, acini and ducts.
VIP-stimulated cAMP formation is negatively
regulated by PKA, PKC and calcium
To establish which AC isoformmediates cAMP generation
by VIP we evaluated their regulation of cAMP formation
by intracellular signals using a number of stimulators
and inhibitors. VIP increased cAMP levels in pancreatic
acini up to 17-fold. In the presence of the PKA
inhibitor H-89 or the PKC inhibitor GF-109203X, an
enhancement up to two-fold in VIP-stimulated cAMP
generation was observed (Fig. 3A). In the presence of
the calcium chelator BAPTA-AM, an enhancement in
VIP-stimulated cAMP generation up to two-fold was
also seen (Fig. 3B). To study further whether the effect
of calcium is direct or indirectly mediated by either
calcineurin or calmodulin, two inhibitors were used:W-7,
which is a calmodulin inhibitor, and FK-506, which is
a calcineurin inhibitor. Neither inhibitor modified the
response to VIP (Fig. 3B), indicating that calcium inhibits
the activity of AC in a direct manner. Several pathway
stimulants including A23187, the phorbol ester PMA and
the muscarinic agonist carbachol were tested, but none
of them stimulated cAMP generation by themselves or
modified VIP-stimulated cAMP generation (Fig. 3C).
Given that PKA, PKC and calcium, in a direct manner,
played a negative regulatory role in cAMP formation,
and neither calcineurin nor calmodulin was involved in
the regulation of cAMP generation, which excludes the
participation of AC9 and AC3, respectively, we hypo-
thesized that the calcium/PKC/PKA-inhibited AC6 plays
an important role in the regulation of pancreatic exocrine
cell activity. To test this hypothesis, mice with a deletion
of AC6 were used.
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Figure 1. Five different AC isoforms are
expressed in the pancreas
Expression of the nine membrane-associated AC
isoforms was assessed in the intact pancreas by
RT-PCR. The brain, kidney and parotid gland were
used as a positive control. RT-PCR products yielded
bands of the expected size (see Supplemental
Table S1). Only AC3, AC4, AC6, AC7 and AC9 are
expressed in the intact pancreas. Results shown are
representative of four experiments.
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Characterization of AC6−/− mice
We first performed RT-PCR analysis and confirmed
that AC6 mRNA expression was absent from AC6−/−
mouse pancreas (Fig. 4A). Using real-time quantitative
PCR we found that the deletion of AC6 does not
modify the expression of other pancreatic AC iso-
forms (Fig. 4B) as previously reported in heart (Tang
et al. 2008). AC6−/− mice show no developmental,
gross morphological (Fig. 4C) or pancreatic histological
abnormalities as shown by haematoxylin and eosin
staining and immunohistochemistry using anti-amylase
antibody as a zymogen granule marker, and anti-keratin
19 antibody as a duct marker (Fig. 5A and B). These
results indicate that AC6 is not required for pancreatic
development andmaintenance of cytoarchitecture, as well
as showing that there are no gross adaptive changes in
AC6−/− mice.
To determine whether AC6 deletion was associated
with alterations of some molecular components of the
pancreas, the protein content of AC9, amylase and keratin
19 was evaluated by Western blotting and no changes
were observed (Fig. 5C). When cAMP is increased, two
pathways are directly activated by cAMP in the exocrine
pancreas: the PKA and Epac1/Rap1 pathways (Chaudhuri
et al. 2007; Sabbatini et al. 2008). Although the AC6
deletion did not affect the protein content of Epac1 or
Rap1, the protein content of the PKA regulatory subunit
was increased (Fig. 5C). Tang et al. (2008) noted that the
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Figure 2. Expression pattern of AC isoforms isolated pancreatic acini, duct fragments and islets
A and B, light micrographs images (A) and RT-PCR analysis of expression of amylase, insulin and keratin 19 (B)
in isolated pancreatic acini, duct fragments and islets. Expression of amylase, insulin and keratin 19 in isolated
pancreatic acini, islets and duct fragments, respectively, indicate the purity of the pancreatic cell preparations.
RT-PCR yielded products of the expected size: amylase, 570 bp; insulin, 108 bp; keratin 19, 374 bp. C, RT-PCR
analysis of expression of different AC isoforms in pancreatic acini, ducts and islets. Expression of AC3, AC4, AC6
and AC9 is found in pancreatic acini whereas expression of AC3, AC4, AC6, AC7 and AC9 is found in pancreatic
ducts and islets. RT-PCR yielded products of the expected size: AC3, 141 bp; AC4, 136 bp; AC6, 123 bp; AC7,
354 bp; AC9, 227 bp.
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Table 1. AC expression in the whole pancreas, isolated acini
and ducts
Pancreas Acini Ducts
Amylase 13.78 ± 0.41 13.02 ± 0.45 24.3 ± 0.64∗∗
Insulin 23.04 ± 0.66 28.49 ± 0.53∗∗ 32.79 ± 1.62∗∗
Keratin 19 37.11 ± 0.79 not detected 33.86 ± 0.52∗
AC3 31.38 ± 0.38 30.15 ± 0.02 31.30 ± 0.19
AC4 31.41 ± 0.46 30.7 ± 1.00 26.63 ± 0.63∗
AC6 29.39 ± 0.72 25.95 ± 0.02∗ 26.33 ± 0.79∗
AC7 34.57 ± 0.41 not detected 32.13 ± 0.38∗
AC9 29.53 ± 0.75 30.02 ± 1.37 30.85 ± 0.95
β-Actin 26.28 ± 0.20 27.70 ± 0.62 25.06 ± 0.43
Real-time quantitative PCR for amylase, insulin, keratin 19
and AC isoform expression in the intact pancreas, iso-
lated pancreatic acini and isolated duct fragments. Data are
expressed as mean cycle threshold (CT) values ± SEM from 3–6
mice. CT values that are statistically significant vs. pancreas are
highlighted in bold. ∗P < 0.05 and ∗∗P < 0.01 vs. pancreas.
protein content of the PKA catalytic subunit is not affected
in AC6−/− mice.
AC6 is required for cAMP/PKA pathway activation
in pancreatic acini
To determine the importance of AC6 in pancreatic acini,
we first measured cAMP formation. VIP, secretin and
forskolin increased cAMP formation in acini from WT
mice up to 8-, 3- and 6-fold, respectively. Deletion of
AC6 did not affect basal cAMP levels in pancreatic acini,
although the absence of AC6 was associated with a
reduction of cAMP formation stimulated by VIP (10 nM),
secretin (100 nM) or forskolin (20μM) by 42, 46 and
53%, respectively (Fig. 6A). We also studied the effect of
AC6 deletion on PKA activity. VIP, secretin and forskolin
increased PKA activity in pancreatic acini from WT mice
up to 4-, 1.75- and 2-fold, respectively. Deletion of AC6
reduced the activation of PKA induced by VIP, secretin
and forskolin by 78, 35 and 65%, respectively (Fig. 6B).
These findings indicate that AC6 is the dominant cAMP
formation-stimulating isoform for VIP-, secretin- and
forskolin-mediated PKA activation.
As a consequence of AC6 deletion, the enhancement of
VIP-stimulated cAMP levels observed in the presence of
the calcium chelator BAPTA-AM was reduced in AC6−/−
mice by 40% (Fig. 7).
AC6 is required for cAMP/PKA pathway activation
in pancreatic duct
Basal cAMP formation from mouse duct fragments
was not affected by the deletion of AC6 (Fig. 8A).
VIP, secretin and forskolin evoked an increase in
cAMP formation from WT mice up to 26-, 16- and
44-fold, respectively. The increase in cAMP formation
induced by VIP, secretin and forskolin was reduced
from AC6−/− mice by 70, 60 and 75%, respectively
(Fig. 8A). VIP, secretin and forskolin increased PKA
activity from WT mice up to 4-, 2.5- and 4-fold,
respectively. The lack of AC6 essentially abolished the
activation of PKA induced by VIP, secretin and forskolin
(Fig. 8B).
Co
nt
ro
l
VI
P
A2
31
87
PM
A
VI
P 
+ 
A
VI
P 
+ 
PM
A
CC
h
CC
h 
+ 
VI
P
0
25
50
75
100
125
150
co
n
tro
l
VI
P
H
-8
9
H
-8
9 
+ 
VI
P G
F
G
F 
+ 
VI
P0
50
100
150
200
*
*
*
†
†
cA
M
P 
le
ve
ls
(pm
ol 
mg
 pr
ote
in–
1 )
Co
nt
ro
l
VI
P
BA
PT
A
BA
PT
A 
+ 
VI
P
W
-7
W
-7
  +
 V
IP
FK
-5
06
FK
-5
06
 +
 C
CK
0
50
100
150
200
cA
M
P 
le
ve
ls
(pm
ol 
mg
 pr
ote
in–
1 )
cA
M
P 
le
ve
ls
(pm
ol 
mg
 pr
ote
in–
1 )
A
C
C
*
*
*
*
†
*
*
* *
Figure 3. VIP-stimulated cAMP formation is negatively
regulated by PKA, PKC and calcium
A and B, the PKA inhibitor H-89, the PKC inhibitor GF-109203X (A)
and the calcium chelator BAPTA-AM (B) all enhance the response to
VIP in pancreatic acini. W-7, which is a calmodulin inhibitor, and
FK-506, which is a calcineurin inhibitor, do not modify the response
to VIP (B). C, the calcium ionophore A23187, the phorbol ester PMA
and the muscarinic agonist carbachol do not modify VIP-stimulated
cAMP generation. GF, GF-109203X; CCh, carbachol. Values are
means ± SEM; n = 5 mice. ∗P < 0.001 vs. control; †P < 0. 001 vs.
VIP alone.
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AC6 is required for amylase secretion
To study the functional relevance of AC6 in pancreatic
acini, amylase secretion was studied. Amylase release was
increased by VIP, secretin and forskolin up to 2-, 1.7- and
2-fold, respectively. Although AC6 deletion did not affect
basal amylase secretion, a reduction in VIP-stimulated
amylase secretionby 31%, aswell as that evokedby secretin
(28%) and forskolin (36%) was observed in AC6−/− mice
(Fig. 9A and B).
AC6 is necessary for evoked pancreatic fluid
The physiological consequence of AC6 deletion on
pancreatic fluid secretion was further studied both in vitro
and in vivo. Isolated sealed pancreatic ducts from WT
WT AC6 -/-
A
B
1000
650
400
100
200
C
WT mice AC6 -/- mice
Body weight (g) 20.9 ± 0.9 20.0 ± 0.7
Pancreas weight (mg) 156 ±11 147 ± 6
Pancreas weight/Body weight
(mg g–1) 7.47 ± 0.33 7.35 ± 0.24
WT mice AC6 -/- mice
AC3 28.88 ± 0.14 29.24 ± 0.05
AC4 32.2 ± 0.37 31.79 ± 0.22
AC7 33.67 ± 0.13 33.09 ± 0.23
AC9 29.99 ± 0.13
β-ACTIN 30.36 ± 0.54 29.40 ± 1.02
30.37 ± 0.16
Figure 4. Characterization of AC6−/− mice
A, mRNA expression of AC6 was present in pancreas from WT mice
(expected size: 350 bp) whereas it was undetectable in pancreas
from AC6−/− mice. B, mRNA expression of AC3, AC4, AC7 and AC9
was analysed by real-time quantitative PCR analysis in both WT and
AC6−/− mice. The deletion of AC6 does not affect the expression of
other pancreatic AC isoforms. Data are expressed as mean cycle
threshold (CT) values ± SEM from four mice. C, no developmental or
gross morphological changes were observed in AC6−/− mice. Age:
45–51 days. Data are expressed as mean ± SEM from 10 mice.
and AC6−/− mice were incubated for 16min at 37◦C in a
bicarbonate-rich medium. The average size of pancreatic
duct fragments without stimulation was 5604± 284μm2
in WT mice and 5980± 278μm2 in AC6−/− mice. No
changes in the lumen area between WT and AC6−/− mice
were observed during this period. Upon VIP stimulation,
a progressive expansion in the lumen was observed in
duct fragments from WT mice up to 2-fold, but there
was no change in lumen area of ducts from AC6−/− mice
(Fig. 10A). A representative image of a duct fragment
before and after VIP stimulation (18min) from WT and
AC6−/− mice is shown in Fig. 11. Further evaluation of the
pancreatic fluid secretion in vivo revealed no change in the
basal secretion from AC6−/− mice. The administration
Epac1
PKA RI
WT AC6 -/-
AC9
amylase
β-Tubulin
keratin19
Rap1
C
B
A
↓
↓
a b
Figure 5. AC6 deletion does not change pancreas morphology
A, pancreas haematoxylin and eosin histological samples of WT (left
panel) and AC6−/− mice (right panel). B, pancreatic acini and ducts
were visualized by immunostaining with anti-amylase (green) and
anti-keratin 19 (red), respectively. The pancreas looks normal; no
morphological changes are observed in AC6−/− mice. Scale
bar = 100 μm. Arrows indicate ducts. C, a representative
immunoblot shows that AC6 deletion does not affect the protein
content of AC9, amylase, keratin 19, Epac1 or Rap1 in total
pancreas lysates. An increase in the protein content of the PKA
regulatory subunit is observed in AC6−/− mice. Equivalent loading
was confirmed using β-tubulin.
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of VIP (0.5μg kg−1, I.V.) and secretin (2 U kg−1, I.V.)
increased pancreatic fluid from WT mice up to 2-fold,
but there was no significant increase in AC6−/− mice
(Fig. 10B).
Response to exogenous cAMP is affected
by AC6 deletion
To address whether the decrease in amylase and fluid
secretion in AC6−/− mice is a consequence solely of
impaired cAMP formation and PKA activation, two
cAMP agonists were used: 8-Br-cAMP and CPT-cAMP.
The cAMP analogues increased PKA activation in
isolated pancreatic acini from WT mice, but their
effects were also reduced in AC6−/− mice (Fig. 12A,
left). 8-Br-cAMP increased PKA activation in duct
fragments from WT mice, but not in AC6−/− mice
(Fig. 12A, right). In isolated pancreatic acini, deletion
of AC6 also impaired the response to CPT-cAMP
on amylase secretion (Fig. 12B). However, deletion
of AC6 did not affect the response to either the
Epac selective analogue 8-pCPT-2′-O-Me-cAMP, or the
calcium-dependent secretagogues CCK or carbachol
(Fig. 12B, right: only concentration–response to CCK is
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Figure 6. Deletion of AC6 reduces the stimulated cAMP
formation and PKA activation in pancreatic acini
The absence of AC6 reduces cAMP formation (A) and PKA activity
(B) in pancreatic acini. FSK, forskolin. n = 6 mice. ∗P < 0.05 and
∗∗P < 0.01 vs. control; †P < 0.05 and ††P < 0.01 vs. WT mice.
shown). When we studied the effect of exogenous cAMP
derivatives in isolatedpancreatic duct fragments,we found
that 8-Br-cAMP evoked a ductal lumen expansion in
WT mice, but not in AC6−/− mice (Fig. 12C). These
findings indicate that the deletion of AC6 affects not
only the response to cAMP-dependent secretagogues, but
also the response to exogenous cAMP, while not affecting
the response to secretagogues signalling through other
pathways.
Discussion
This study demonstrates that pancreatic exocrine cells
express multiple AC isoforms: AC3, AC4, AC6 and AC9
are expressed in both pancreatic acini and ducts whereas
AC7 is expressed only in pancreatic ducts.
Depending on the relative levels of the isoforms
expressed in a cell type, extracellular signals received by the
G-protein coupled receptor can be differently integrated.
AC activity can be regulated by α subunits of Gs, Gi, Gz
and Go, βγ subunits of G protein, PKA, PKC isoforms,
changes in membrane potential and calcium in a direct or
indirect manner (Sadana & Dessauer, 2009). Specifically
in the exocrine pancreas, an increase in diacylglycerol and
calcium through 1,4,5-IP3 receptors induces an activation
of PKC (Williams & Yule, 2012), which in turn could
activate AC3, and AC7. Calcium can activate calcineurin
(Groblewski et al. 1998; Gurda et al. 2008), and thereby
could inhibit AC9, and via activation of calmodulin kinase
II (Duan et al. 1994) inhibit AC3. In this study we found
that AC6 is the primary isoform regulating the response to
cAMP-mobilized secretagogues because: (1) the response
to VIP was enhanced by PKA and PKC inhibitors, as well
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Figure 7. AC6 is negatively regulated by calcium in pancreatic
acini
The lack of AC6 largely impairs the enhancement of VIP-stimulated
cAMP levels observed in the presence of the calcium chelator BAPTA.
GF, GF109203X. Values are means ± SEM; n = 5 mice. ∗P < 0.05
and ∗∗∗P < 0.001 vs. control; †P < 0.05 vs. WT mice; ‡P < 0.001 vs.
VIP alone.
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
3702 M. E. Sabbatini and others J Physiol 591.15
as by a depletion of calcium. No change in the response to
VIP was observed in the presence of either the calmodulin
inhibitor or the calcineurin inhibitor, which indicates
that both the calcium/calmodulin-stimulated AC3 and
the calcium/calcineurin-inhibited AC9 are unlikely to
participate in VIP-stimulated cAMP formation; and (2)
isolated pancreatic acini from mice with targeted AC6
deletion showed a reduction in cAMP formation and
PKA activity in response to VIP, secretin and forskolin,
and as a consequence, a reduction in amylase secretion
from AC6−/− mice was shown. We also studied the
importance of AC6 in the function of pancreatic ducts.
We observed that in AC6−/− mice both cAMP formation
and PKA activation were abolished in response to VIP,
secretin and forskolin. We also found that AC6 plays a
physiologically relevant role in pancreatic ducts because
the VIP-stimulated expansion of the lumen observed in
pancreatic ducts fromWTmice uponVIP stimulationwas
absent in duct fragments from AC6−/− mice. Collection
of pancreatic fluid in vivo also showed a decrease in fluid
secretion from AC6−/− mice.
The deletion of AC6 not only affected the response
to cAMP-dependent secretagogues, but also the response
A
B
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
***
***
††
†††
†
*
cA
M
P 
le
ve
ls
(pm
ol 
mg
 pr
ote
in–
1 )
0
1000
2000
3000
4000
5000
**
**
**
†† † ††
PK
A 
ac
tiv
ity
(ng
 ac
tiv
e P
KA
 µg
 pr
ote
in–
1 )
AC6:
Stimulus:
AC6:
Stimulus:
+ - + - + - + -
none VIP secretin FSK
+ - + - + - + -
none VIP secretin FSK
Figure 8. The lack of AC6 reduces the stimulated cAMP
formation and PKA activity in isolated pancreatic ducts
Deletion of AC6 reduces cAMP formation (A) and PKA activity (B) in
pancreatic ducts. FSK, forskolin. Values are means ± SEM; n = 6
mice. ∗P < 0.05, ∗∗P < 0.01 vs. control; †P < 0.05 and ††P < 0.01
vs. WT mice.
to cAMP replacement using 8-Br-cAMP or CPT-cAMP,
although Western blotting showed an increase in protein
content of the PKA regulatory subunit. Unlike cAMP/PKA
signalling, the deletion of AC6 did not affect either
calcium or Epac1 signalling because the effect of
calcium-mobilized secretagogues or the Epac1 selective
analogue on amylase secretion was not modified in
AC6−/− mice. No changes in the morphology of the
pancreas or in the protein content of other molecular
elements of the exocrine pancreas, such as amylase,
keratin 19, Epac1 and Rap1, have been observed. These
findings indicate that AC6 plays an important selective
role in cAMP/PKA signalling and that the increase in
protein content of the PKA regulatory subunit is not
enough to compensate for the lack of AC6. We suggest
that AC6 deletion impairs the PKA pathway and, as a
consequence, these cells no longer respond to cAMP.
If so, it emphasizes the importance of AC6 in these
cells.
The deletion of AC6 slightly reduced VIP-, secretin-
or forskolin-stimulated amylase secretion. It is likely
that the residual responses were mediated by other
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Figure 9. Stimulated amylase secretion is reduced from
AC6−/− mice
A, concentration–response curve to VIP on amylase secretion. B,
effect of a single concentration of VIP (10 nM), secretin (100 nM) and
forskolin (FSK) (20 μM) on amylase secretion. n = 6 mice. ∗P < 0.05
and ∗∗P < 0.01 vs. control. †P < 0.05 and ††P < 0.01 vs. AC6
mice.
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
J Physiol 591.15 Role of AC6 in pancreatic amylase and fluid secretion 3703
AC isoforms expressed in pancreatic acini and/or
by the cAMP-dependent PKA-independent pathway,
Epac1, which has participated in cAMP-stimulated
amylase secretion (Chaudhuri et al. 2007; Sabbatini
et al. 2008). The result showing the deletion of
AC6 does not affect the response to the Epac1
analogue 8-pCPT-2′-O-Me-cAMP on amylase secretion
supports this hypothesis. Unlike amylase secretion,
cAMP-dependent secretagogue-stimulated fluid secretion
was highly dependent onAC6 activity because the deletion
of AC6 completely blocked the expansion of the duct
fragment in vitro, as well as pancreatic fluid secretion
in vivo. A relatively higher transcript level of AC6 in
both pancreatic acini and ducts can explain its physio-
logical relevance. It is also possible that the intracellular
conditions favour the activation of AC6. For example, AC6
may have a greater sensitivity to Gs-activated secretin and
VPAC receptors than other AC isoforms.
AC activation increases cAMP accumulation in isolated
ducts, which in turn activates PKA, which phosphorylates
CFTR in the apical membrane of the duct cells (Argent
et al. 2012). Elevationof intracellular cAMPby stimulation
with forskolin significantly inhibits the Na/H exchanger
and this, like the stimulation of the apical anion exchanger,
may occur through a direct physical interaction with
CFTR (Argent et al. 2012). The basolateral Cl−/HCO3−
exchanger (AE) does not seem to be directly activated
by forskolin (Lee et al. 1999). Based on this knowledge,
it is likely that AC6 is responsible for the activation of
CFTR, and indirectly, for the inhibition of the Na/H
exchanger and the apical anion exchanger. Because the
direct evidence of AC6 on the activity of transporters
is beyond the scope of the paper, we did not test this
hypothesis further.
Given that AC6 is the only AC isoform regulated by
Gαi, the presence of AC6 in the exocrine pancreas has
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Figure 10. The absence of AC6 impairs the response to secretagogues in pancreatic fluid secretion in
isolated duct fragments and in anaesthetized mice
A, an expansion in the lumen of sealed isolated duct fragments was observed in WT mice upon VIP (10 nM)
stimulation while no change in lumen area was observed in duct from AC6−/− mice. n = 8–9 duct fragments in
each group. B, stimulation by VIP (0.5 μg kg−1, I.V.) or secretin (2 U kg−1, I.V.) increased pancreatic fluid secretion
in anaesthetized WT mice but not in AC6−/− mice. Values are means ± SEM; n = 3–4 mice. ∗P < 0.05, ∗∗P < 0.01
vs. control. †P < 0.05 vs. WT mice.
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previously been suggested because in rabbit pancreatic
acini the inhibition of Gαi activity by pertussis toxin
stimulates cAMP formation without affecting calcium
mobilization or amylase secretion (Willems et al. 1987). In
addition to this observation, because somatostatin inhibits
AC activity through somatostatin type 2 receptor (ss2R)
receptors coupled to the Gαi subunit (Matsushita et al.
1993; Ohnishi et al. 1994), it is likely that AC6 mediates
the response to somatostatin in pancreatic acini.
AC7 participates in the synergistic effect of Gα12/13 on
Gs-stimulated cAMP production in HEK cells (Jiang et al.
2008). The lack of AC7 expression in pancreatic acini is
consistent with our previous results which demonstrated
that the expression of p115-RGS, which is an regulator
of G protein signaling domain of p115-RhoGEF and an
inhibitor of Gα12/13 (Chen et al. 2003), does not modify
VIP-induced cAMP production in mouse pancreatic acini
(Sabbatini et al. 2010). The significance of the higher
expression of this isoform in pancreatic ducts remains
to be determined.
Changes in cytosolic calcium levels are known to
either enhance or impair cAMP generation through
calcium-sensitive AC isoforms. AC1 and AC8 are the
 
A B
C D
Figure 11. The absence of AC6 impairs the secretory response
to VIP in isolated duct fragments
A and B, a representative duct fragment before (A) and after VIP
stimulation (10 nM) (B) from WT mice. C and D, a representative duct
fragment before (C) and after VIP stimulation (D) from AC6−/− mice.
The lumen area is drawn in green. An expansion in lumen area is
observed in sealed duct fragments from WT mice (area:
16267.03 μm2 vs 20993.34 μm), but not from AC6−/− mice (area:
5124.47 μm2 vs 4996.56 μm2).
major calcium-activated isoforms whereas AC5 and AC6
are calcium-inhibited AC isoforms. The presence of only
AC6 indicates the existence of a mechanism of regulation
which is activated by an increase in cytosolic calcium.
AC8 has been shown to be responsible for calcium
stimulation of cAMP production in mouse parotid acini
(Watson et al. 2000). The authors showed the lack of a
stimulatory effect of calcium on cAMP generation in iso-
lated parotid acini from AC8−/− mice. In parotid acini,
unlike in pancreatic acini, calcium is able to increase cAMP
formation, which is the primary signal for parotid amylase
secretion (Seino & Shibasaki, 2005). The lack of AC8
expression in mouse pancreatic acini is consistent with
the lack of a stimulatory response to calcium in cAMP
generation.
AC9 is the most divergent in sequence of the
membrane-bound isoforms and the only isoform which
is not stimulated by forskolin (Premont et al. 1996;
Sadana &Dessauer, 2009). AC9 is inhibited by calcineurin
(Cooper, 2003), which is present in pancreatic acini
(Groblewski et al. 1998; Gurda et al. 2008), and involved
in pancreatic adaptive growth (Tashiro et al. 2004),
as well as in caerulein-induced intracellular pancreatic
zymogen activation (Husain et al. 2007). AC9 is stimulated
by calcium/CaMKII phosphorylation (Cumbay & Watts,
2005), which is also present in pancreatic acini and
activated by CCK (Duan et al. 1994). The currently
available validated antibodies allowed us to document
the presence of AC9 at the protein level in the pancreas.
Unfortunately, antibodies to other AC isoforms we tested
did not work on mouse pancreas. Future studies may
be better carried out on human tissues because most
large-scale antibody projects use human sequences as anti-
gens.
cAMP can be produced either by membrane-associated
AC or by the soluble AC (AC10) (Buck et al. 1999).
Recently, AC10 has been found in pancreatic acini and
shown to be possibly involved in the development of
pancreatitis, but not in physiological events (Kolodecik
et al. 2012).
In conclusion, in the exocrine pancreas activation of
AC occurs after the stimulation by secretagogues VIP and
secretin, which acting through activation of VPACs and
secretin receptors, respectively, activates Gαs. Multiple AC
isoforms are differentially expressed in mouse pancreatic
acini and ducts: AC3, AC4, AC6 and AC9 are expressed in
pancreatic acini and ducts whereas AC7 is expressed only
in pancreatic ducts. We found that in pancreatic exocrine
cells AC6 plays a critical role in cAMP/PKA-mediated
signalling. AC6 deletion decreased cAMP generation, as
well as in the activity of PKA in both pancreatic acini and
ducts. As a consequence, a decrease in amylase secretion
and pancreatic fluid occurred. The role and importance
of other AC isoforms will require future studies in which
these isoforms are deleted or inhibited.
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Figure 12. The response to exogenous cAMP is impaired in AC6−/− mice
In the presence of cAMP analogues PKA activation (A), amylase secretion (B) and lumen expansion (C) were
studied in WT and AC6−/− mice. A, the absence of AC6 reduces the effect of cAMP analogues 8-Br-cAMP
(500 μM) and CPT-cAMP (500 μM) to activate PKA in isolated pancreatic acini (left panel) while it abolishes the
effect of 8-Br-cAMP in isolated duct fragments (right panel); n = 5–12. B (left), deletion of AC6 reduces the
effect of VIP (10 nM) and CPT-cAMP (CPT) (100 μM), but not 8-pCPT-2′-O-Me-cAMP (Epac) (100 μM), CCK (30 pM)
or CCh (10 μM) on amylase secretion; n = 5–9. B (right), concentration–response curve to CCK; n = 5 in each
group. C, an expansion in the lumen of sealed isolated pancreatic duct fragments is observed in WT mice upon
8-Br-cAMP (500 μM) stimulation while no change in lumen area is observed in duct from AC6−/− mice; n = 5–7
duct fragments from six mice in each group. ∗P < 0.05, ∗∗P < 0.01 vs. control. †P < 0.05 vs. WT mice.
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Translational perspective
Adenylyl cyclase (AC) isoforms are differentially expressed inmouse pancreatic acini, ducts and islets.
To study the importance of AC6 in pancreatic physiology, AC6-deficient mice were used. Deletion
of AC6 has a negative effect on the function of pancreatic exocrine cells: the lack of AC6 not only
reduces amylase secretion but also impairs fluid secretion from pancreatic ducts. The participation
of AC6 in pancreatic pathophysiology is of clinical interest.
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